Product Information
AIRDUO RESPICLICK 232-14 MCG is a brand product labeled by Teva Respiratory, LLC, priced at $385.1574 per EA under NDC 59310082206. Its NADAC has been published 126 times since Jan 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Fluticasone Propionate and Salmeterol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
232; 14 ug/1; ug/1
Manufacturer
Teva Respiratory, LLCNDC
59310082206
Classification
Brand
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/18/2025
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
New Drug (NDA)
FDA Application
NDA208799On Market Since
4/12/2017
Pharmacological Classes
Price Statistics
The NADAC for AIRDUO RESPICLICK 232-14 MCG has been published 126 times since Jan 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $385.1574 per EA |
|---|---|
| All-time high | $387.1333 (Mar 12, 2025) |
| All-time low | $384.9229 (Apr 17, 2024) |
| 52-week high | $385.1574 |
| 52-week low | $385.1574 |
| Median price | $385.7100 |
| Average price | $385.6942 |
| Largest weekly change | -0.3% (Jun 18, 2025) |
| Weeks tracked | 126 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AIRDUO RESPICLICK 232-14 MCG?
The current National Average Drug Acquisition Cost (NADAC) for AIRDUO RESPICLICK 232-14 MCG, manufactured by Teva Respiratory, LLC, is $385.1574 per EA (NDC 59310082206), effective Jun 10, 2026.
How has the price of AIRDUO RESPICLICK 232-14 MCG changed over time?
Over the history we have for it, the NADAC for AIRDUO RESPICLICK 232-14 MCG has held within roughly two percent of its current level. It has been tracked across 126 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for AIRDUO RESPICLICK 232-14 MCG?
Since Jan 17, 2024, the NADAC for AIRDUO RESPICLICK 232-14 MCG has ranged from a low of $384.9229 (Apr 17, 2024) to a high of $387.1333 (Mar 12, 2025), with a median of $385.7100 per EA.
Are there cheaper alternatives to AIRDUO RESPICLICK 232-14 MCG?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FLUTICASONE-SALMETEROL 232-14, is $103.3827 per EA — about 73% below AIRDUO RESPICLICK 232-14 MCG.
Who manufactures AIRDUO RESPICLICK 232-14 MCG?
AIRDUO RESPICLICK 232-14 MCG (NDC 59310082206) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification